Physician profile
Christopher Scott Highfill
NPI 1790778389
$10,841.70
in general payments reported to CMS, 2019-2025
8 companies · $866 in 2025
The $866 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,706 · 2020: $2,511 · 2021: $40.65 · 2022: $346 · 2023: $1,795 · 2024: $2,577 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,935 · Food and Beverage: $1,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,934.54 |
| Food and Beverage | $1,303.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,523.05 | 2019-2024 | Distal Extremities Implants Soft Tissue Ib Ligament Augmentation |
| Fortis Surgical, LLC | $2,132.52 | 2020-2024 | |
| Depuy Synthes Sales INC. | $1,023.00 | 2019-2025 | Velys |
| Medical Device Business Services, INC. | $46.20 | 2025 | Velys |
| Stryker Corporation | $40.65 | 2021 | |
| Integra Lifesciences Corporation | $40.17 | 2019 | |
| Acumed LLC | $20.10 | 2024 | Acumed, Osteomed |
| Endo Pharmaceuticals INC. | $16.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Highfill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.